Anxiety disorders as comorbid conditions in neuropsychiatric diseases in children

• Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova Vol. 124; no. 7; p. 56
• Main Authors: Zavadenko, N N, Nesterovskiy, Yu E, Zavadenko, A N, Shypilova, E M
• Format: Journal Article
• Language: English; Russian
• Published: Russia (Federation) 2024
• Subjects: Adolescent; Anxiety Disorders - epidemiology; Attention Deficit Disorder with Hyperactivity - epidemiology; Autism Spectrum Disorder - complications; Autism Spectrum Disorder - epidemiology; Autism Spectrum Disorder - psychology; Child; Comorbidity; Humans; Migraine Disorders - epidemiology; Migraine Disorders - psychology; Neurodevelopmental Disorders - epidemiology; Quality of Life; comorbidity; attention deficit hyperactivity disorder; Tenoten for children; specific learning disabilities; anxiety disorders; autism spectrum disorders; speech and language development disorders; headache
• ISSN: 1997-7298
• DOI: 10.17116/jnevro202412407156

The variants of heterotypic comorbidity of anxiety disorders (AD) with attention deficit hyperactivity disorder, autism spectrum disorders, speech and language development disorders, specific learning disabilities (dyslexia, dysgraphia, dyscalculia), migraine, tension type headache in children and adolescents are discussed. In cases of heterotypic comorbidity the patients with AD referrals to specialists may be primarily associated with their emotional problems. Meanwhile, the comorbidity of AD with these diseases leads to a deterioration of their clinical manifestations and a worsening of the prognosis, and anxiety symptoms often not only persist, but also increase with age. It should be borne in mind that AD in children with neurodevelopmental disorders contribute to a decrease in the quality of life, academic failure, have a negative impact on peer relationships and the family environment, and in young adulthood, patients have an increased risk of depression and substance abuse. Therefore, early intervention and a comprehensive therapeutic approach with a dynamic assessment of the patient's condition are becoming important. When choosing pharmacotherapy, it is advisable to choose medictions that have a complex effect on the pathogenetic mechanisms of the underlying disease and concomitant AD, which include Tenoten for children.